pharmaceutical investing Acerus Announces Results of Phase 1 Clinical Trial with a Proprietary Intranasal Formulation of a Tetrahydrocannabinol-Rich Cannabis Oil
pharmaceutical investing Acerus Provides Update on Continuing Commercial and R&D Achievements for NATESTO®
pharmaceutical investing Acerus Announces Expansion of NATESTO® Agreement with medac and the Submission of NATESTO® Dossier in Europe
Maritime Resources: A Low-risk Path to Gold Production in One of the World’s Top Mining Jurisdictions
Homerun Resources Inc. Announces New Homerun Energy Website and "The Hub" AI-Powered Platform for Energy Management